CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Find out the essential elements to check in your credit card rewards statements. This knowledge can help you optimize your rewards strategy.
18,067 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Federal data show a sharp decline in ACA enrollment as subsidies expired, with about 3 million fewer people insured i...
When Netflix drops its biggest series debut of 2026, millions tune in. The real lesson isn’t just about TV—it's about...
Meme coins began as jokes, yet a few have established serious market presence. This guide analyzes whether meme coins...
Aave's price surge near $94.32 on June 27 sparked talk that DeFi lending is entering a bank-like phase, with governan...
A sweeping heat wave tests whether workers should work during heat and how cooling costs and productivity shifts thre...
Savers are exploring dividend income to take home an electrician’s paycheck, but the capital required hinges on yield...
Accenture warns AI’s carbon footprint could rise 11-fold by 2030 as data centers multiply worldwide. The piece examin...
A wave of fresh research notes on Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesfo...
A century-old Augusta brokerage steers through consolidation by leaning into relationships, local knowledge, and a pe...
June’s job gains slowed dramatically to 57,000, with May and April revisions lowering earlier totals. The economy dis...
The Fed kept its policy rate unchanged, setting the stage for a slow drift in HYSA yields. Savers await any signal fr...